Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2028 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

ISTA Reports Two Preliminary Results Of T-Pred Studies

ISTA Pharmaceuticals (ISTA) has reported preliminary results from two recently completed studies on its investigational ophthalmic product, T-Pred (prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension). Reportedly, the

FDA Approves ISTA’s Bepreve Eye Drop

FDA has approved ISTA Pharmaceuticals’ (ISTA) Bepreve (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients

Care-Tech Signs Consent Decree With FDA

The FDA has reported that Care-Tech Laboratories (Care-Tech) and its principal officers, John Brereton and Sherry Brereton, have signed a consent decree, agreeing to stop the illegal manufacture,

Galenica Acquires OM PHARMA To Expand Business

Swiss pharmaceutical and retail company Galenica has acquired the entirety of OM PHARMA, a biotechnology and pharmaceutical Swiss company. Acquisition is expected to increase Galenica’s internationalisation by contributing

USPTO Publishes Stemedica’s Patent Application

The US Patent and Trademark Office (USPTO) publishes Stemedica Cell Technologies’ (Stemedica) patent application for the treatment of Diabetic Retinopathy. Reportedly, the application is supported by extensive data